Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dana Chase
OpenAlex ID:
A5159610311
Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial
2026
·
Domenica Lorusso
, Jérôme Martin-Babau
, et al.
·
The Lancet
·
1
Show more works
View as search
Works count:
1
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type
